Publication
Increased 3-O-sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene HS3ST1
Downloadable Content
- Persistent URL
- Last modified
- 06/25/2025
- Type of Material
- Authors
-
-
Zhangjie Wang, UNC Eshelman School of PharmacyVaishail N Patel, National Institute of Dental and Craniofacial Research (NIDCR)Xuehong Song, Byrd Alzheimer’s Center and Research InstituteYongmei Xu, UNC Eshelman School of PharmacyAndrea M Kaminski, National Institute of Environmental Health Sciences (NIEHS)
- Language
- English
- Date
- 2023-05-26
- Publisher
- American Association for the Advancement of Science
- Publication Version
- Copyright Statement
- © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 9
- Issue
- 21
- Start Page
- eadf6232
- End Page
- eadf6232
- Grant/Funding Information
- J.L. lab at UNC has received a gift from Glycan Therapeutics to support research in glycosciences.
- Supplemental Material (URL)
- Abstract
- HS3ST1 is a genetic risk gene associated with Alzheimer's disease (AD) and overexpressed in patients, but how it contributes to the disease progression is unknown.We report the analysis of brain heparan sulfate (HS) from AD and other tauopathies using a LC-MS/MS method. A specific 3-O-sulfated HS displayed sevenfold increase in the AD group (n = 14, P < 0.0005). Analysis of the HS modified by recombinant sulfotransferases and HS from genetic knockout mice revealed that the specific 3-O-sulfated HS is made by 3-O-sulfotransferase isoform 1 (3-OST-1), which is encoded by the HS3ST1 gene. A synthetic tetradecasaccharide (14-mer) carrying the specific 3-O-sulfated domain displayed stronger inhibition for tau internalization than a 14-mer without the domain, suggesting that the 3-O-sulfated HS is used in tau cellular uptake. Our findings suggest that the overexpression of HS3ST1 gene may enhance the spread of tau pathology, uncovering a previously unidentified therapeutic target for AD.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Pharmacology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - w731t.pdf | Primary Content | 2025-06-02 | Public | Download |